-
DiscoveryProbe Protease Inhibitor Library: Precision in Prot
2026-06-03
Leverage the DiscoveryProbe™ Protease Inhibitor Library for high-throughput, cell-permeable screening in cancer and apoptosis research. This resource delivers robust coverage, automation-ready formats, and advanced troubleshooting to unlock mechanistic insights into protease modulation.
-
Rucaparib (AG-014699): Protocol Enhancements in DNA Repair R
2026-06-03
Rucaparib (AG-014699) empowers cancer biology research with precise PARP1 inhibition, enabling advanced radiosensitization and DNA repair pathway interrogation. This guide delivers actionable workflows, key troubleshooting, and the latest insights from Pol II degradation studies to optimize your experimental outcomes.
-
Antipyrine: Benchmark for CNS Drug Permeability & PK Researc
2026-06-02
Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is a validated analgesic and antipyretic agent, widely used as a reference compound in blood-brain barrier and pharmacokinetic studies. Its excellent solubility and high purity make it a cornerstone in pain and fever research, facilitating robust, reproducible workflows.
-
Dibutyryl-cAMP, Sodium Salt: Transforming cAMP Signaling Wor
2026-06-02
Dibutyryl-cAMP, sodium salt empowers researchers to activate and dissect cAMP signaling with precision, offering robust solubility and stability for demanding workflows. Drawing from cutting-edge endometrial research and established neural differentiation protocols, this guide spotlights practical applications, troubleshooting, and innovations for advanced cAMP pathway studies.
-
ARCA EGFP mRNA: Engineering Assay Reliability and Translatio
2026-06-01
Discover how ARCA EGFP mRNA advances fluorescence-based gene expression analysis in mammalian cells. This in-depth guide reveals the molecular engineering and practical considerations that set enhanced green fluorescent protein mRNA apart as a robust mRNA transfection control.
-
Toremifene in Breast Cancer: 20 Years of Clinical Evidence
2026-06-01
This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator, for the treatment of estrogen receptor-positive breast cancer. The findings highlight the importance of molecular profiling and personalized endocrine therapy in optimizing patient outcomes.
-
Selective BCL-XL Inhibitor A-1155463: Advanced Cancer Resear
2026-05-31
A-1155463 stands out as a benchmark selective BCL-XL inhibitor, enabling robust apoptosis induction in BCL-XL-dependent cancer models. This article translates recent mechanistic and workflow advances into actionable strategies for overcoming tumor drug resistance and optimizing experimental reliability.
-
Deferoxamine (DeferoxamineB): Iron Chelator for Oncology Res
2026-05-30
Deferoxamine (DeferoxamineB) is a validated iron chelator with potent antiproliferative, apoptosis-inducing, and autophagy-modulating effects. Its molecular action underpins key advances in regulated cell death research and metabolic intervention strategies for cancer. The compound's solubility, storage, and usage parameters are well-established, supporting reproducibility in biomedical workflows.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-29
Wang et al. uncover a novel METTL16-SENP3-LTF signaling axis that confers resistance to ferroptosis and promotes tumor development in hepatocellular carcinoma. Their mechanistic findings link RNA methylation with iron metabolism, offering new targets for sensitizing HCC to ferroptosis-based therapies.
-
GMDS Drives Core Fucosylation in MYCN-Amplified Neuroblastom
2026-05-29
This study identifies GDP-mannose 4,6-dehydratase (GMDS) as a crucial regulator of core fucosylation and tumorigenesis in MYCN-amplified neuroblastoma. By linking N-MYC–mediated transcriptional control of GMDS to aggressive tumor behavior, the findings reveal a metabolic vulnerability that could inform targeted therapies.
-
Ruxolitinib Phosphate Induces Apoptosis and Pyroptosis in AT
2026-05-28
This study uncovers that ruxolitinib phosphate (INCB018424) triggers both apoptosis and GSDME-dependent pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting DRP1-mediated mitochondrial fission via JAK1/2-STAT3 pathway suppression. These findings highlight a novel mechanism of action for JAK/STAT pathway modulation in aggressive thyroid cancers with limited therapeutic options.
-
Mubritinib (TAK 165): Optimizing Complex I Inhibition in Can
2026-05-28
Mubritinib (TAK 165) enables precise, targeted inhibition of mitochondrial electron transport chain complex I, selectively inducing cytotoxicity in chemotherapy-resistant AML and KSHV-positive lymphoma models. This guide details advanced workflows, troubleshooting strategies, and protocol enhancements to maximize the translational value of Mubritinib in cancer biology and HER2-driven research.
-
Acifran: Structural Precision in Lipid Metabolism Research
2026-05-27
Acifran, a selective HM74A/GPR109A and GPR109B agonist, is reshaping lipid metabolism research through mechanistic clarity and validated receptor targeting. This article offers translational researchers strategic guidance, blending new structural insights, workflow best practices, and a forward-looking vision for metabolic disorder studies. By anchoring discussion in high-resolution cryo-EM findings and practical laboratory integration, we demonstrate how Acifran advances the field beyond conventional compound listings.
-
Dacarbazine: Precision Workflows for Antineoplastic Chemothe
2026-05-27
Unlock the full potential of Dacarbazine through optimized in vitro and translational protocols, leveraging its alkylating power for malignant melanoma, Hodgkin lymphoma, and sarcoma research. This guide bridges bench-proven workflows with troubleshooting insights, translating recent systems biology innovations into actionable lab strategies.
-
Rotavirus Drives Nrf2 Pathway Suppression via Proteasomal De
2026-05-26
This study reveals that progressive rotavirus infection sharply downregulates the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes via enhanced proteasomal degradation, independent of classical redox or turnover pathways. These findings reshape our understanding of viral manipulation of host antioxidant defenses and offer mechanistic insight for redox enzyme function probes in antiviral and oxidative stress research.